Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.01.09.630316

Is there a pathological switch that triggers the onset of renal calcification?

Abstract

IntroductionNephrocalcinosis, nephrolithiasis and Randalls plaque formation are distinct renal pathologies of biomineralization predominantly originating in the renal papillae. Experimental evidence on the events leading to the initial aggregation of nanometer-scale plaque or stone deposits in these regions are limited. Cellular plasticity is a regulatory mechanism of disease progression, and can lead to the transition of epithelial to mesenchymal stem-cell-like phenotypes, and generate macrophages to trigger pathophysiological alterations underlying renal biomineralization. We aim to understand the pathological mechanisms of biomineralization at the renal papillary tip of clinical patient samples and develop functional assays to analyze mechanisms of disease progression within organ-chip devices in vitro. MethodsWe analyzed clinical cohorts of patient renal papillae tissues obtained via nephrectomy (n=34) categorized as stone formers (SF) vs. non-stone formers (NSF). We studied the histopathology and genetic (bulk RNA-sequencing) composition of patient samples in the two groups. We examined the role of primary cells, including peripheral blood mononuclear cells (PBMCs) - progenitors of macrophages, isolated from patient blood samples to differentiate M1 pro and M2 anti-inflammatory macrophage phenotypes for static culture and flow/stretch analyses on organ-on-a-chip devices (Emulate Inc). We stained tissue sections with histology dyes and conducted digital pathology multiplexing analyses via quantitative pathology software (quPath, GitHub) by training an artificial neural network. We conducted fluorescence in situ hybridization (FISH) studies to identify genetic biomarkers of inflammation extracted from the bulk-RNA sequencing data. ResultsBased on the initial results of digital pathology, we identified renal calcium deposits (p value = 0.0017), collagen deposits (p value = 0.0001), fibrosis (p value = 0.0385) and renal casts or inflammatory cells among SF vs NSF cohorts across the cortex-to-tip region of renal papillae. Bulk RNA-sequencing analyses were primarily conducted with DAVID-KEGG and Panther 17.0 classification databases to highlight key regulatory pathways of interest involved at the onset of renal biomineralization, such as the oxidative stress pathway, hypoxia response via HIF activation, and inflammation mediated by chemokine and cytokine signaling. The FISH studies identified genes involved with inflammation; GALNT3, PLEKHO1, SLCO2A1, and VCAM1. We successfully differentiated patient-derived PBMCs to M1 and M2 macrophage lineages to study the impact of oxidative stress by using static 35 mm plate and flow microfluidic organ-chip instruments, to conduct appropriate functional assays in cell culture. ConclusionThe study outcomes provide insights to the precursors of renal biomineralization and delineated the expression of a pathological switch at the onset of hypoxia. The data will provide a fundamental framework to isolate primary cells from patient samples to conduct cell culture studies under static conditions, and translate the outcomes to flow analyses on a Kidney Chip instrument (Emulate. Inc) to mimic pathological conditions in a microphysiological environment in vitro. The ultimate outcome of this project will lead to the development of functional assays that emulate the kidney microphysiology on an organ-chip instrument, suited for clinical translation as a personalized, precision diagnostics and therapeutics platform.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jeewandara, T. M.. 2025-01-13. Is there a pathological switch that triggers the onset of renal calcification?. https://doi.org/10.1101/2025.01.09.630316

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Surfactant-Assisted Colorimetric Signal Enhancement in Paper-Based Glucose Sensing

Paper-based colorimetric sensors offer a low-cost and accessible platform for point-of-care (POC) analysis, but enzyme activity loss during coating and drying can weaken analytical signals and require high enzyme loadings or complex immobilization procedures. Although surfactants are widely used to improve wettability in paper-based assays, their potential contribution to colorimetric performance beyond these effects remains unclear. Here, we investigated surfactant-assisted colorimetric signal enhancement in a glucose assay implemented on a 96-puddle paper plate (96-PPP) and identified Tween 20 as the most effective surfactant. Its effect on detection performance became more pronounced as glucose oxidase (GOx) loading decreased; at 0.1 mg/mL GOx, Tween 20 lowered the limit of detection (LoD) from 0.113 to 0.034 mg/mL (approximately 3.3-fold) over a working range of 0-5 mg/mL, despite no statistically significant change in the measured contact angle at this loading. Tween 20 had no appreciable effect on the reaction in solution but preserved 95% of the apparent reaction rate constant after drying, compared with 11% without it, and atomic force microscopy (AFM) revealed a more dispersed dried enzyme morphology on mica. Tween 20-containing sensors also showed slower signal decay during repeated wetting-drying cycles and thermal stress, retained 77% (vs 26%) of the response at 400 mM NaCl, and exhibited within-PPP and between-batch coefficients of variation (CVs) below 10% (vs 12.3-19.5%), while maintaining glucose selectivity over potentially interfering molecules. These results indicate that Tween 20 enhances paper-based glucose sensing beyond wettability, in part by retaining enzyme cascade activity during drying, although the contributions of the individual enzymes and the underlying mechanism remain to be established.

bioengineering↗

Engineering CAR-T cells to remodel the mucin-rich cancer cell glycocalyx

The dense glycocalyx of cancer cells can restrict immune-cell access to surface antigens and limit CAR-T cell activity. Here, we show that mucin density and epitope position determine how glycocalyx remodeling affects CAR-T cell recognition and killing. We identify KLK5 as a human protease that cleaves tumor-associated mucins, increases access to membrane-proximal antigens, and enhances CAR-T cell function. We then engineer CAR-T cells to display or secrete KLK5, enabling remodeling of the tumor glycocalyx during antigen recognition. KLK5-engineered CAR-T cells improved tumor control across multiple xenograft models, and KLK5-secreting MUC17 CAR-T cells produced the strongest in vivo benefit, prolonging survival compared with conventional MUC17 CAR-T cells. These findings show that CAR-T cells can be engineered to breach the mucin-rich glycocalyx while preserving accessible target epitopes.

bioengineering↗

Wall stiffening is a primary contributor to motility loss in Crohn's disease: an electromechanical modeling study

Fibrotic strictures are among the most disabling complications of Crohn's disease, permanently narrowing the bowel and impairing motility, yet no approved therapy reverses them. Chronic inflammation alters pacemaker-network coupling, smooth-muscle excitability, and calcium-dependent contractility, while fibrosis thickens the bowel wall, narrows the lumen, and changes tissue mechanics. The relative contributions of these coupled electrical, contractile, and structural alterations to motility loss remain unclear. To address this gap, we develop an integrated electromechanical finite-element framework for fibrostenosing Crohn's disease that couples a fibrosis-driven growth model with a FitzHugh-Nagumo electromechanical model. A full-factorial 25 design of experiments is used to quantify the relative effects of electrical diffusivity, excitation threshold, peak active stress, wall stiffness, and hypertrophic remodeling on cyclic lumen-volume deformation. Motility is quantified by the standard deviation of lumen volume over one contraction cycle. Within the parameter ranges examined, increased wall stiffness emerged as the dominant contributor to motility loss, followed by impaired smooth-muscle contractility. Changes in excitation threshold, hypertrophic remodeling, and electrical diffusivity produced substantially smaller effects. Pairwise interactions were small relative to the dominant main effects, indicating that the mechanisms contributed largely through their individual effects. Our findings suggest that limiting wall stiffening while preserving smooth-muscle contractile function may provide a therapeutic strategy for maintaining intestinal motility in fibrostenosing Crohn's disease.

bioengineering↗